Positive outcomes of the Australian Teletrial Program in the regional setting of South West Healthcare

Abstract

The Australian Teletrial Program (ATP) has supported regional and rural hospitals, including South West Healthcare (SWH), to expand access to clinical trials by strengthening infrastructure and engagement with both communities and clinicians. Since the program began, seven teletrials have been implemented, with one more currently in start-up. Notably, five of these are non-oncology trials, reflecting a broader scope of research activity. ATP funding has supported both sponsored and non sponsored trials, with $700 per participant per year helping to offset costs not fully covered by trial budgets, such as travel, medical appointments, and essential equipment. This funding has also enabled regional sites like SWH to act as satellite sites under primary sites, improving patient access and reducing the need for travel. At SWH, funding has enabled the Clinical Trials Unit to acquire two new pieces of equipment, saving staff time and reducing participant burden. Additional support has enhanced promotion and community engagement through targeted activities and resources. Overall, this has helped reduce financial barriers and improve participation in clinical trials across multiple sites. The program has also created opportunities for medical and nursing staff to participate in research as Associate Investigators, allowing them to gain experience without the full responsibilities of a Principal Investigator role. This supports workforce development and builds future research capacity. Collaboration with the Victorian and Queensland Regional Clinical Trial Coordinating Centres (RCCC) has further strengthened networks with sponsors, universities, and metropolitan hospitals, supporting ongoing trial activity beyond the program ’ s duration. ATP funding has also supported two Project Officer roles at SWH, contributing to feasibility assessments, trial start-up, coordination, and process improvements. This has enhanced efficiency and overall capability within the Clinical Trials Unit. Overall, the ATP has achieved its goal of increasing access to clinical trials closer to home, enabling patients in regional, rural, and remote areas to access innovative treatments that may otherwise be unavailable.